As of Jul 22
| -0.11 / -1.10%|
The 6 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 19.00, with a high estimate of 24.00 and a low estimate of 14.00. The median estimate represents a +92.89% increase from the last price of 9.85.
The current consensus among 6 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.